Indeed, anti-diabetic drugs, such as metformin, intranasal insulin, incretins, SGLT2 inhibitors, PPAR-γ agonists and DPP4 inhibitors are now being investigated in the context of AD treatment and prevention. The gene discussed is INS; the disease is Alzheimer disease.